Measuring Costs of Cardiovascular Disease Prevention for Patients with Familial Hypercholesterolemia in Administrative Claims Data.

Lauren E Passero Megan C Roberts

Published in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2024)

Lipid testing and lipid-lowering medications for cardiovascular disease prevention generate substantial real-world costs which can be used to improve cost-effectiveness models of familial hypercholesterolemia screening and care management.

Keyphrases

cardiovascular disease
healthcare
type diabetes
fatty acid
palliative care
health insurance
electronic health record
big data
quality improvement
coronary artery disease
affordable care act
machine learning